Clinical Trial Results

Showing: All studies [change]
Condition: Lupus Location: Arvada, Colorado 13 trials found
New Search
Filter
Trial Phase
Study Type
PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
PHASE4INTERVENTIONAL La Mesa, California +4 more
RECRUITING
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
N/AOBSERVATIONAL Denver, Colorado
RECRUITING
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
PHASE2INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
PHASE2INTERVENTIONAL Loma Linda, California +4 more
RECRUITING
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
PHASE3INTERVENTIONAL Avondale, Arizona +4 more
RECRUITING
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
PHASE1INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
PHASE1INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
VIBRANT: VIB4920 for Active Lupus Nephritis
PHASE2INTERVENTIONAL La Jolla, California +4 more
RECRUITING
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type